Bollina P - Search Results

1

Functional and quality of life outcomes of localised prostate cancer treatments (Prostate Testing for Cancer and Treatment [ProtecT] study).

Lane JA, Donovan JL, Young GJ, Davis M, Walsh EI, Avery KNL, Blazeby JM, Mason MD, Martin RM, Peters TJ, Turner EL, Wade J, Bollina P, Catto JWF, Doherty A, Gillatt D, Gnanapragasam V, Hughes O, Kockelbergh R, Kynaston H, Oxley J, Paul A, Paez E, Rosario DJ, Rowe E, Staffurth J, Neal DE, Hamdy FC, Metcalfe C; Prostate Testing for Cancer and Treatment (ProtecT) Study Group. Lane JA, et al. Among authors: bollina p. BJU Int. 2022 Sep;130(3):370-380. doi: 10.1111/bju.15739. Epub 2022 May 3. BJU Int. 2022. PMID: 35373443 Free PMC article. Clinical Trial.

2

The localisation and expression of 5 alpha-reductase types I and II mRNAs in human hyperplastic prostate and in prostate primary cultures.

Habib FK, Ross M, Bayne CW, Grigor K, Buck AC, Bollina P, Chapman K. Habib FK, et al. Among authors: bollina p. J Endocrinol. 1998 Mar;156(3):509-17. doi: 10.1677/joe.0.1560509. J Endocrinol. 1998. PMID: 9582508

3

Radical radiotherapy and salvage cystectomy as the primary management of transitional cell carcinoma of the bladder. Results following the introduction of a CT planning technique.

Borgaonkar S, Jain A, Bollina P, McLaren DB, Tulloch D, Kerr GR, Howard GC. Borgaonkar S, et al. Among authors: bollina p. Clin Oncol (R Coll Radiol). 2002 Apr;14(2):141-7. doi: 10.1053/clon.2002.0055. Clin Oncol (R Coll Radiol). 2002. PMID: 12069124

4

The loss of 5alpha-reductase type I and type II mRNA expression in metastatic prostate cancer to bone and lymph node metastasis.

Habib FK, Ross M, Bayne CW, Bollina P, Grigor K, Chapman K. Habib FK, et al. Among authors: bollina p. Clin Cancer Res. 2003 May;9(5):1815-9. Clin Cancer Res. 2003. PMID: 12738739

5

Nitric oxide donating nonsteroidal anti-inflammatory drugs induce apoptosis in human prostate cancer cell systems and human prostatic stroma via caspase-3.

Royle JS, Ross JA, Ansell I, Bollina P, Tulloch DN, Habib FK. Royle JS, et al. Among authors: bollina p. J Urol. 2004 Jul;172(1):338-44. doi: 10.1097/01.ju.0000132367.02834.41. J Urol. 2004. PMID: 15201807

6

Trends in reporting Gleason score 1991 to 2001: changes in the pathologist's practice.

Ghani KR, Grigor K, Tulloch DN, Bollina PR, McNeill SA. Ghani KR, et al. Eur Urol. 2005 Feb;47(2):196-201. doi: 10.1016/j.eururo.2004.07.029. Eur Urol. 2005. PMID: 15661414

7

Results of a definitive study are needed to provide guidance on the treatment of patients with screen-detected, 'low-grade' prostate cancer.

Stewart GD, Riddick AC, Bollina PR, McNeill SA. Stewart GD, et al. Among authors: bollina pr. BJU Int. 2006 Nov;98(5):944-5. doi: 10.1111/j.1464-410X.2006.06540.x. BJU Int. 2006. PMID: 17034595 No abstract available.

8

Multiple loci with different cancer specificities within the 8q24 gene desert.

Ghoussaini M, Song H, Koessler T, Al Olama AA, Kote-Jarai Z, Driver KE, Pooley KA, Ramus SJ, Kjaer SK, Hogdall E, DiCioccio RA, Whittemore AS, Gayther SA, Giles GG, Guy M, Edwards SM, Morrison J, Donovan JL, Hamdy FC, Dearnaley DP, Ardern-Jones AT, Hall AL, O'Brien LT, Gehr-Swain BN, Wilkinson RA, Brown PM, Hopper JL, Neal DE, Pharoah PD, Ponder BA, Eeles RA, Easton DF, Dunning AM; UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons' Section of Oncology; UK ProtecT Study Collaborators. Ghoussaini M, et al. J Natl Cancer Inst. 2008 Jul 2;100(13):962-6. doi: 10.1093/jnci/djn190. Epub 2008 Jun 24. J Natl Cancer Inst. 2008. PMID: 18577746 Free PMC article.

9

Development of a complex intervention improved randomization and informed consent in a randomized controlled trial.

Donovan JL, Lane JA, Peters TJ, Brindle L, Salter E, Gillatt D, Powell P, Bollina P, Neal DE, Hamdy FC; ProtecT Study Group. Donovan JL, et al. Among authors: bollina p. J Clin Epidemiol. 2009 Jan;62(1):29-36. doi: 10.1016/j.jclinepi.2008.02.010. Epub 2008 Jul 10. J Clin Epidemiol. 2009. PMID: 18619811 Clinical Trial.

10

Current strategies for monitoring men with localised prostate cancer lack a strong evidence base: observational longitudinal study.

Metcalfe C, Tilling K, Davis M, Lane JA, Martin RM, Kynaston H, Powell P, Neal DE, Hamdy F, Donovan JL; ProtecT Study Group. Metcalfe C, et al. Br J Cancer. 2009 Aug 4;101(3):390-4. doi: 10.1038/sj.bjc.6605181. Epub 2009 Jul 14. Br J Cancer. 2009. PMID: 19603015 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

54 results

Search Page